Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 2—February 2002

Research

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

David P. Speert*, Deborah Henry*, Peter Vandamme†, Mary Corey‡, and Eshwar Mahenthiralingam*
Author affiliations: *University of British Columbia and Children’s and Women’s Health Centre of British Columbia, Vancouver, British Columbia, Canada; †University of Ghent, Ghent, Belgium; ‡The Hospital for Sick Children, Toronto, Ontario, Canada

Main Article

Table 2

Genomovar or species of Burkholderia cepacia complex or phenotypically similar isolates from cystic fibrosis patients in Canada

Species or genomovar No. of patients infected with species or genomovara Percentage of patients (%)
Genomovar I 1 0.2
Burkholderia multivorans (genomovar II) 43 9.3
Genomovar III 369 80.0
Burkholderia stabilis (genomovar IV) 17 3.8
Burkholderia vietnamiensis (genomovar V) 7 1.6
Burkholderia cepacia complex (not genomovar I-VII) 8 1.8
Burkholderia fungorum 1 0.2
Burkholderia gladioli 5 1.1
Ralstonia pickettii 5 1.1
Pandoraea spp.
5
1.1
Total 461

aSome patients were counted twice if two or more different strains were recovered.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO